Latest filing published 01 Oct 2026 for Oric Pharmaceuticals, Inc., €90k. Read the official filing
Richard A, Heyman is a declared insider of Oric Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 6 July 2026 and the latest from 1 October 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 1 October 2026, reports a transaction of €90k in Oric Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations